A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...